MAC Clinical Research (United Kingdom)

Alternate names: MAC Clinical Research, MAC Clinical Research Ltd.

ROR: 03sffks27

OpenAlex ID: I4405267663

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

2012 · R. M. Langford, J. Mares, et al. · Journal of Neurology · 309

A double‐blind, randomized, placebo‐controlled, parallel group study of THC / CBD spray in peripheral neuropathic pain treatment

2014 · M. Serpell, S. Ratcliffe, et al. · European Journal of Pain · 205

Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

2018 · Thomas Werfel, Gary Layton, et al. · Journal of Allergy and Clinical Immunology · 141

Randomised, Multicentre, Placebo-controlled, Double-blind Crossover Study Investigating the Effect of Solifenacin and Oxybutynin in Elderly People with Mild Cognitive Impairment: The SENIOR Study

2013 · Adrian Wagg, Mark Dale, et al. · European Urology · 140

Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis

2015 · Cris S. Constantinescu, Aliya Asher, et al. · Neurology Neuroimmunology & Neuroinflammation · 114

PDF

The role of working memory and attentional disengagement on inhibitory control: effects of aging and Alzheimer's disease

2012 · Trevor J. Crawford, Steve Higham, et al. · AGE · 101

A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain

2014 · B. Hoggart, S. Ratcliffe, et al. · Journal of Neurology · 92

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial

2025 · Stephen Macfarlane, Timo Grimmer, et al. · The Journal of Prevention of Alzheimer s Disease · 71

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial

2022 · Kara N. Stevens, Siobhan Creanor, et al. · JAMA Neurology · 57

PDF

A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis

2017 · Arthur J. Mayorga, Christopher M. Flores, et al. · Scandinavian Journal of Pain · 51

Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial

2023 · Richard T. Bryan, Sarah J. Pirrie, et al. · JAMA Network Open · 32

PDF

Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial

2019 · L.C. Rovati, N. Brambilla, et al. · Osteoarthritis and Cartilage · 31

PDF

Abstract 14387: Dose-Related Reductions in Blood Pressure With a RNA Interference (RNAi) Therapeutic Targeting Angiotensinogen in Hypertensive Patients: Interim Results From a First-In-Human Phase 1 Study of ALN-AGT01

2020 · Stephen A Huang, Jorg Taubel, et al. · Circulation · 22

A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389) a potent, oral histamine H4, receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults

2016 · Thomas Werfel, Victoria Lynch, et al. · Journal Der Deutschen Dermatologischen Gesellschaft · 15

Phase 1 Study of the Safety and Pharmacokinetics of CSL889 (Hemopexin) in Adults with SCD

2024 · Paul M Shore, Bart J Biemond, et al. · Journal of sickle cell disease. · 5

Abstract 10974: Durable Reductions in Circulating Angiotensinogen and Blood Pressure Six Months After Single Doses of ALN-AGT, an RNA Interference Therapeutic Targeting Hepatic Angiotensinogen Synthesis, in Hypertensive Patients

2021 · Stephen Huang, Jorg Taubel, et al. · Circulation · 5

Safety, Pharmacodynamics, and Blood Pressure Effects of Aln-agt, an Rna Interference Therapeutic Targeting Angiotensinogen, in a Randomized Single Ascending Dose Study of Hypertensive Adults

2021 · Stephen A. Huang, Jorg Taubel, et al. · Journal of Hypertension · 5

Comparative evaluation of swabbing sites for Omicron variant detection in PCR testing

2024 · Tom Fowler, Edward Blandford, et al. · Diagnostic Microbiology and Infectious Disease · 4

The evaluation of a multi-day testing approach with antigen lateral flow devices for people eligible for community-based COVID-19 treatments

2023 · Tom Fowler, Alasdair Fellows, et al. · Journal of Antimicrobial Chemotherapy · 4

PDF

First in Human study of a microRNA29a mimic (TenoMiR) in patients with lateral elbow tendinopathy - a randomised, Placebo Controlled Phase 1 trial

2025 · Neal L Millar, Iona Donnelly, et al. · medRxiv · 2

PDF

Ab0810 Intra-articular Cntx-4975 for Painful Knee Osteoarthritis: Assessment of Cooling Methods for Reducing Procedural Pain

2019 · Randall Stevens, Kimberly Guedes, et al. · Annals of the Rheumatic Diseases · 2

PDF

Phase I study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with sickle cell anemia

2026 · Bart J. Biemond, Rachel Kesse-Adu, et al. · Haematologica · 1

PDF

Predicting 30-day mortality after hospital admission for heart failure: the National Heart Failure Audit for England and Wales

2026 · Andrew L Clark, Rumana Z Omar, et al. · Heart · 1

PDF

Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease Patients

2025 · Stephen Macfarlane, Timo Grimmer, et al. · medRxiv · 1

PDF

Reply from Authors re: Jean-Nicolas Cornu. Overactive Bladder Medical Management in the Elderly: It Is Time to Go Beyond the Tip of the Iceberg. Eur Urol 2013;64:82–3

2013 · Adrian Wagg, Mark Dale, et al. · European Urology · 1

Works count: 33

Citation count: 3,493